Urovant Sciences


Urovant Sciences, innovations in urology. Our lead therapeutic candidate is vibegron (RVT-901), an investigational oral β3-adrenergic agonist

Industries

Employees

11-50

Links


Org chart

James Robinson
President & CEO
Collapse
Betzy Estrada
EVP & Chief Human Resources Officer
Laura Genatossio
SVP & General Manager, Europe
Mark Niemaszek
SVP, Corporate Planning
Alana Darden Powell
VP, Marketing
Achsah Warren
Vice President Compliance

Board & advisors

Keith Katkin
Advisor to the Board
James M. Hindman
Board Member
Pierre Legault
Board Member


Offices